Chemours (NYSE: CC) reported Q3 EPS of $1.49, $0.07 better than the analyst estimate of $1.42. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.71 billion.

GUIDANCE:

Chemours sees Q4 2018 EPS of $5.10-$5.85, versus the consensus of $5.84.

For earnings history and earnings-related data on Chemours (CC) click here.